France· FR:67624035
WILFACTIN 100 UI/mL, poudre et solvant pour solution injectable
A medicinal product containing facteur willebrand de coagulation humain, registered in France by LFB-BIOMEDICAMENTS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FACTEUR WILLEBRAND DE COAGULATION HUMAIN
- Manufacturer
- LFB-BIOMEDICAMENTS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
- cip1334009564513881 flacon(s) en verre de 10 g de poudre - 1 flacon(s) en verre de 10 ml de solvant avec dispositif(s) de transfert
- cip1334009585101061 flacon(s) en verre de 5 g de poudre - 1 flacon(s) en verre de 5 ml de solvant avec dispositif(s) de transfert
- cip1334009585102741 flacon(s) en verre de 20 g de poudre - 1 flacon(s) en verre de 20 ml de solvant avec dispositif(s) de transfert
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Facteur willebrand de coagulation humain in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumHaemate P 1200 IE vWF/500 IE FVIII 1200 IU - 500 IUCSL Behring
- SwedenWillfact 1000 IE Pulver och vätska till injektionsvätska, lösningLFB-BIOMEDICAMENTS
- SpainWILLFACT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLELfb Biomedicaments
- PolandWillfact 1000 j.m.LFB-Biomedicaments
- FinlandWilfactinLFB Biomedicaments
- United KingdomWillfact 1,000unit powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- GermanyWillfactLfb Biomedicaments
- CzechiaWILLFACTLFB-BIOMEDICAMENTS, Courtaboeuf
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Willfact
- Belgium · Wilfactin
- Czechia · Willfact
- Germany · Willfact
- Denmark · Willfact
- Spain · Willfact
- Finland · Haemate, Wilfactin
- United Kingdom (Northern Ireland) · Willfact
- Greece · Haemate P, Wilfactin
- Italy · Wilfactin
- Netherlands · Wilfactin
- Norway · Willfact
- Poland · Willfact
- Sweden · Willfact
- Slovakia · Willfact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdb69bb1-1e09-4bdd-ac4f-6b7cfd2e3d2c GET /v1/drugs/fdb69bb1-1e09-4bdd-ac4f-6b7cfd2e3d2c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67624035",
"date_amm": "2003-09-30",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "FACTEUR WILLEBRAND DE COAGULATION HUMAIN",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about facteur willebrand de coagulation humain.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.